Caixin
Caixin Global – Latest China News & Headlines

Home >

TRENDING
Video Streamer iQiyi Apologizes for Milk Gimmick Gone Sour
TikTok Retains Crown as World’s Top Non-Game App Despite 50% Drop in Downloads
Singaporean Ride-Hailing Firm Grab to Launch New Services for Premium Passengers, Pet Owners
LATEST
Singapore-Based E-Commerce Aggregator Una Brands Raises $40 Million for Asia-Pacific Acquisitions
Video Streamer iQiyi Apologizes for Milk Gimmick Gone Sour
Singaporean Ride-Hailing Firm Grab to Launch New Services for Premium Passengers, Pet Owners
TikTok Retains Crown as World’s Top Non-Game App Despite 50% Drop in Downloads
Tencent Reportedly Negotiating Risk-Mitigation Measures to Retain U.S. Gaming Investments
Foxconn to Set Up Chipmaking Joint Venture with Yageo
Excluding Chinese Vendors from Indian 5G Trials Will Hold Back Development, Diplomat Says
Alibaba-Backed MYBank Eyes Deeper Penetration Into Under-Banked Rural China
Vivo and Oppo Claim Top Two Spots in China Smartphone Market as Huawei Falls
U.S. Urges TSMC to Prioritize Supplies to American Carmakers Grappling with Global Chip Shortage
Indonesian Ride-Hailing Unicorn Gojek Aims to Go All Electric by 2030
Tencent-Backed Insurtech Firm Waterdrop Aims to Raise up to $360 Million in U.S. IPO
Which Money-Losing Electric-Car Makers Have Tied Up With Huawei?
Video Platform Bilibili to Buy Stake in Mobile-Game Maker CMGE to Boost Content
Baidu to Roll Out Driverless Robotaxis in Beijing in May
Tesla Challenger Nio Shrinks Losses as Sales Surge
Trending in China: A Beijing Bureaucrat Worked as Delivery Driver for a Day and Earned Just $6
Fjord Focus: Why Are Chinese Electric-Car Makers Flocking to Norway?
Alibaba Has Big Plans for Taobao’s Livestreaming Hawking Business
Xiaomi Extends Reign as India’s Smartphone King Despite Slipping Market Share

By Charlotte Yang / Dec 11, 2018 07:10 PM / Economy

Photo: VCG

Photo: VCG

Changsheng Bio-Technology, which in a high-profile scandal earlier this year was revealed to have fabricated data on its vaccines for infants, has received an advance notification of mandatory delisting from the Shenzhen Stock Exchange.

The exchange described the vaccine-maker's illegal activities as “seriously damaging to national interests and public interests.”

In a separate announcement, the company said the China Securities Regulatory Commission fined 17 related personnel for market violations, banned four from entering China’s stock markets for life, and three from entering the market for five years.

Related: Data-Faking Vaccine Firm to Be Kicked Off Stock Exchange Under New Rules


Share this article
Open WeChat and scan the QR code